NCT07334964

Brief Summary

This study aims to assess the feasibility, safety, and accuracy of a robotic arm-assisted carpal tunnel injection in comparison with the conventional ultrasound-guided method, prior to conducting a larger-scale study. The use of a robotic arm to maintain the ultrasound probe in position could provide valuable assistance to the physician. The procedure would no longer require the involvement of a third person in addition to the physician. To date, no study has compared these two approaches.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Nov 2025Feb 2027

Study Start

First participant enrolled

November 25, 2025

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2027

Last Updated

January 12, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

December 22, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

carpal tunnel syndromerobot-assited-ultrasonographycarpal tunnel injection

Outcome Measures

Primary Outcomes (1)

  • Comparison of the variation of the VAS scale on the Ultrasound-Guided Carpal Tunnel Injection between the Manual Method and a Robot-Assisted Method

    VAS: Scale 1 to 10 with 1 is no pain at all and 10 is the worst pain that the participant can imagine.

    This outcome is measured on the day of the intervention (Day 0) after randomization and a month after the intervention (Day 28)

Secondary Outcomes (8)

  • Pain VAS at D7 and 3 months

    This outcome is measured on Day 0 (D0) after randomization, Day 7 (D7), Day 28 (D28), and Month 3 (M3)

  • Compare the evolution of the BCTQ (Boston Carpal Tunnel Questionnaire, subscale SSS) score over time according to the method (Arm A versus Arm B)

    This outcome is measured on Day 0 (D0) after randomization, Day 7 (D7), Day 28 (D28), and Month 3 (M3)

  • Compare the evolution of the BCTQ (Boston Carpal Tunnel Questionnaire, subscale FSS) score over time according to the method (Arm A versus Arm B)

    This outcome is measured on Day 0 (D0) after randomization, Day 7 (D7), Day 28 (D28), and Month 3 (M3)

  • Compare the duration of the procedure according to the method (Arm A versus Arm B)

    This outcome is measured on Day 0 (D0) after randomization

  • Assess the procedure related pain

    This outcome is measured n Day 0 (D0) after randomization and Day 7 (D7),

  • +3 more secondary outcomes

Study Arms (2)

Manual (Arm A)

ACTIVE COMPARATOR

Ultrasound-guided carpal tunnel injection using the conventional method: An ultrasound-guided carpal tunnel injection is performed using manual guidance. The operator first identifies the median nerve using an ultrasound probe. The operator then applies aseptic conditions. Subsequently, the operator holds the ultrasound probe in one hand and the medication in the other, and performs the injection while referring to the ultrasound image to ensure accurate needle placement.

Procedure: Carpal tunnel injection

Robot-Assisted (Arm B)

EXPERIMENTAL

Ultrasound-guided carpal tunnel injection assisted by a robotic arm: The operator first identifies the median nerve using an ultrasound probe tied back to the robotic arm. The operator then places both themselves and the probe attached robotic arm under aseptic conditions. The robotic arm is subsequently positioned to obtain the desired ultrasound imaging plane. The operator then has both hands free to perform the injection, referring to the ultrasound image to ensure accurate needle placement.

Procedure: Carpal tunnel injection

Interventions

Ultrasound localization will be performed by the physician. He will then perform the injection under ultrasound guidance. In Group A, maintenance of the ultrasound probe during the injection will be performed by the physician assisted by a nurse. In Group B, maintenance of the ultrasound probe during the injection will be performed by the robotic arm. All other aspects of the procedure will be carried out according to usual standards (localization, aseptic technique, injection, etc…). The procedure will be timed from the initial positioning (first contact of the ultrasound probe with the wrist) to the end of the injection (needle withdrawal). Maintenance of participant blinding during the injection: a drape will be placed between the physician and the participant; the robot will be activated in both groups, the participant will wear anti noise headphones, and a nurse will be present in both groups.

Manual (Arm A)Robot-Assisted (Arm B)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 and ≤ 75 years.
  • Clinical diagnosis of carpal tunnel syndrome.
  • Indication for corticosteroid injection as determined by investigator.
  • Moderate to severe carpal tunnel syndrome defined by a pain score on the Visual Analogue Scale (VAS) ≥ 4 (at baseline and on day 0).
  • Signed informed consent.

You may not qualify if:

  • Known allergy to corticosteroids or povidone-iodine (Betadine)
  • Probable or ongoing systemic or local infection
  • History of injection in the affected wrist within the last 6 months
  • Thenar eminence atrophy
  • Trauma requiring surgery or immobilization
  • History of carpal tunnel surgery
  • Protected person (under guardianship or curatorship)
  • Person under judicial protection
  • Person deprived of liberty
  • Person not affiliated with a social security scheme
  • Pregnant or breastfeeding woman
  • Person participating in a drug trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Orléans

Orléans, 45067, France

RECRUITING

Related Publications (10)

  • Lam KHS, Wu YT, Reeves KD, Galluccio F, Allam AE, Peng PWH. Ultrasound-Guided Interventions for Carpal Tunnel Syndrome: A Systematic Review and Meta-Analyses. Diagnostics (Basel). 2023 Mar 16;13(6):1138. doi: 10.3390/diagnostics13061138.

    PMID: 36980446BACKGROUND
  • Goswami RP, Sit H, Chatterjee M, Lahiri D, Sircar G, Ghosh P. High-resolution ultrasonography in carpal tunnel syndrome: role of ancillary criteria in diagnosis and response to steroid injection. Clin Rheumatol. 2021 Mar;40(3):1069-1076. doi: 10.1007/s10067-020-05228-8. Epub 2020 Jul 21.

    PMID: 32696280BACKGROUND
  • Lee JY, Park Y, Park KD, Lee JK, Lim OK. Effectiveness of ultrasound-guided carpal tunnel injection using in-plane ulnar approach: a prospective, randomized, single-blinded study. Medicine (Baltimore). 2014 Dec;93(29):e350. doi: 10.1097/MD.0000000000000350.

    PMID: 25546691BACKGROUND
  • Mehta SP, Weinstock-Zlotnick G, Akland KL, Hanna MM, Workman KJ. Using Carpal Tunnel Questionnaire in clinical practice: A systematic review of its measurement properties. J Hand Ther. 2020 Oct-Dec;33(4):493-506. doi: 10.1016/j.jht.2019.12.011. Epub 2020 Mar 7.

    PMID: 32151499BACKGROUND
  • Leite JC, Jerosch-Herold C, Song F. A systematic review of the psychometric properties of the Boston Carpal Tunnel Questionnaire. BMC Musculoskelet Disord. 2006 Oct 20;7:78. doi: 10.1186/1471-2474-7-78.

    PMID: 17054773BACKGROUND
  • Jiang A, Qian Y, Yan J, Zhang S, Zhu S. Corticosteroid injection for carpal tunnel syndrome: A meta-analysis comparing ultrasound guided approach with landmark approach. Pak J Med Sci. 2024 Mar-Apr;40(4):773-778. doi: 10.12669/pjms.40.4.8749.

    PMID: 38545011BACKGROUND
  • Priester AM, Natarajan S, Culjat MO. Robotic ultrasound systems in medicine. IEEE Trans Ultrason Ferroelectr Freq Control. 2013 Mar;60(3):507-23. doi: 10.1109/TUFFC.2013.2593.

    PMID: 23475917BACKGROUND
  • Scheibert A, Preuss M, Osburg J, Ernst F, Kleemann M, Horn M. Robotic Assisted Ultrasound-Guided Endovascular Stent Implantation in a Vascular Model. Int J Med Robot. 2024 Dec;20(6):e70005. doi: 10.1002/rcs.70005.

    PMID: 39501897BACKGROUND
  • Eilers C, van Kemenade R, Busam B, Navab N. On the importance of patient acceptance for medical robotic imaging. Int J Comput Assist Radiol Surg. 2023 Jul;18(7):1261-1267. doi: 10.1007/s11548-023-02948-5. Epub 2023 May 29.

    PMID: 37248427BACKGROUND
  • Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de Jong B. Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract. 2010 Jul 29;11:54. doi: 10.1186/1471-2296-11-54.

    PMID: 20670438BACKGROUND

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Camille LANGBOUR, Dr

    CHU Orléans

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
blinding during injection: a vertical drape blocking the view between the operator and the participant; the robot activated in both groups (noise), noise-reduction system for the patient (noise-canceling headset on the participant's ears, use of earphones, etc.), nurse present in both groups
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: There are 2 arms with an equal number of patient randomized in a parallel way.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 12, 2026

Study Start

November 25, 2025

Primary Completion (Estimated)

November 25, 2026

Study Completion (Estimated)

February 25, 2027

Last Updated

January 12, 2026

Record last verified: 2026-01

Locations